Israeli researcher receives EU grant for development of 'electronic nose'

An Israeli researcher has been awarded a grant of € 1.73 million by the EU under its Marie Curie Excellence programme for the development of an 'electronic nose' that can sniff out cancer.

Dr Hossam Haick of the Israel Institute of Technology received the award as part of the EU's efforts to strengthen and encourage young promising scientists.

Dr Haick is 31 years old and also the recipient of the largest grant ever received from the EU by an Israeli researcher. He will be working on artificial olfactory systems or 'electronic noses' aimed at sniffing out and diagnosing cancer at the earliest possible stage before it spreads.

"Realisation of the research goal will enable creating an instrument based on nanometre-sized sensors that can diagnose different cancers and even determine at what stage the disease is," explains Dr Haick. "The diagnosis can be carried out at a very early stage even before the tumour has begun to spread. Thus, treatment will be immediate and will destroy the disease at its inception."

Electronic noses are one example of a growing research area called biomimetics, or biomimicry, which involves human-made applications patterned on natural phenomena.

As an odour is composed of molecules, each of which has a specific size and shape, each of these molecules has a receptor of a corresponding size and shape in the human nose. When a specific receptor receives a molecule, it sends a signal to the brain and the brain identifies the smell associated with that particular molecule. Electronic noses based on the biological model work in a similar manner, substituting sensors for the receptors, and transmitting the signal to a program for processing, instead of the brain.

Dr Haick intends to develop sensor arrays made of nanomaterials, understanding the fundamental chemical, physical, and electrical properties of these nanomaterials and the signal mechanism of these sensors.

He will also be developing the smallest versions of these electronic noses; the 'e-nose on chip', which is a single computer chip containing both the sensors and the processing components.

In addition, to targeting the early diagnosis, detection and screening of a disease, artificial olfactory systems are used in environmental-monitoring, the food industries and security.

For further information, please visit: Technion - Israel Institute of Technology

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...